Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.05 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.021 | 0.7 |